#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Micronutrients are essential to orchestrate all physiological functions .
3-1	17-31	Micronutrients	substance	new	ana	4-2
3-2	32-35	are	_	_	_	_
3-3	36-45	essential	_	_	_	_
3-4	46-48	to	_	_	_	_
3-5	49-60	orchestrate	_	_	_	_
3-6	61-64	all	abstract[4]	new[4]	_	_
3-7	65-78	physiological	abstract[4]	new[4]	_	_
3-8	79-88	functions	abstract[4]	new[4]	_	_
3-9	89-90	.	_	_	_	_

#Text=Among them , iodine ( I ) plays a unique role because it is the main component of the thyroid hormones , i. e. , thyroxine ( T4 ) and triiodothyronine ( T3 ) .
4-1	91-96	Among	_	_	_	_
4-2	97-101	them	substance	giv	_	_
4-3	102-103	,	_	_	_	_
4-4	104-110	iodine	substance	new	coref	9-16
4-5	111-112	(	_	_	_	_
4-6	113-114	I	person	acc	ana	5-13
4-7	115-116	)	_	_	_	_
4-8	117-122	plays	_	_	_	_
4-9	123-124	a	abstract[8]	new[8]	ana	4-13[0_8]
4-10	125-131	unique	abstract[8]	new[8]	_	_
4-11	132-136	role	abstract[8]	new[8]	_	_
4-12	137-144	because	_	_	_	_
4-13	145-147	it	abstract	giv	coref	4-15[10_0]
4-14	148-150	is	_	_	_	_
4-15	151-154	the	abstract[10]	giv[10]	_	_
4-16	155-159	main	abstract[10]	giv[10]	_	_
4-17	160-169	component	abstract[10]	giv[10]	_	_
4-18	170-172	of	abstract[10]	giv[10]	_	_
4-19	173-176	the	abstract[10]|substance[12]	giv[10]|new[12]	_	_
4-20	177-184	thyroid	abstract[10]|object|substance[12]	giv[10]|new|new[12]	coref	5-3
4-21	185-193	hormones	abstract[10]|substance[12]	giv[10]|new[12]	_	_
4-22	194-195	,	_	_	_	_
4-23	196-198	i.	_	_	_	_
4-24	199-201	e.	_	_	_	_
4-25	202-203	,	_	_	_	_
4-26	204-213	thyroxine	substance	new	_	_
4-27	214-215	(	_	_	_	_
4-28	216-218	T4	abstract	new	_	_
4-29	219-220	)	_	_	_	_
4-30	221-224	and	_	_	_	_
4-31	225-241	triiodothyronine	substance	new	_	_
4-32	242-243	(	_	_	_	_
4-33	244-246	T3	abstract	new	_	_
4-34	247-248	)	_	_	_	_
4-35	249-250	.	_	_	_	_

#Text=Since the thyroid gland regulates many metabolic processes , the extent of I requirement strongly depends on the age and stage of development of the individual .
5-1	251-256	Since	_	_	_	_
5-2	257-260	the	place[18]	new[18]	coref	6-14[31_18]
5-3	261-268	thyroid	object|place[18]	giv|new[18]	coref	6-15
5-4	269-274	gland	place[18]	new[18]	_	_
5-5	275-284	regulates	_	_	_	_
5-6	285-289	many	abstract[20]	new[20]	_	_
5-7	290-299	metabolic	person|abstract[20]	new|new[20]	coref	5-25[27_0]
5-8	300-309	processes	abstract[20]	new[20]	_	_
5-9	310-311	,	_	_	_	_
5-10	312-315	the	abstract[21]	new[21]	_	_
5-11	316-322	extent	abstract[21]	new[21]	_	_
5-12	323-325	of	abstract[21]	new[21]	_	_
5-13	326-327	I	abstract[21]|person|abstract[23]	new[21]|giv|new[23]	ana|ana	7-10|7-10
5-14	328-339	requirement	abstract[21]|abstract[23]	new[21]|new[23]	_	_
5-15	340-348	strongly	_	_	_	_
5-16	349-356	depends	_	_	_	_
5-17	357-359	on	_	_	_	_
5-18	360-363	the	abstract[24]	new[24]	_	_
5-19	364-367	age	abstract[24]	new[24]	_	_
5-20	368-371	and	_	_	_	_
5-21	372-377	stage	abstract[25]	new[25]	ana	6-4[28_25]
5-22	378-380	of	abstract[25]	new[25]	_	_
5-23	381-392	development	abstract[25]|abstract[26]	new[25]|new[26]	coref	6-26[34_26]
5-24	393-395	of	abstract[25]|abstract[26]	new[25]|new[26]	_	_
5-25	396-399	the	abstract[25]|abstract[26]|person[27]	new[25]|new[26]|giv[27]	_	_
5-26	400-410	individual	abstract[25]|abstract[26]|person[27]	new[25]|new[26]|giv[27]	_	_
5-27	411-412	.	_	_	_	_

#Text=Thus , when the I demand is not satisfied , reduced functionality of the thyroid gland could occur ( hypothyroidism ) with negative consequences for proper mental development , body growth , and fertility .
6-1	413-417	Thus	_	_	_	_
6-2	418-419	,	_	_	_	_
6-3	420-424	when	_	_	_	_
6-4	425-428	the	abstract[28]	giv[28]	_	_
6-5	429-430	I	abstract[28]	giv[28]	_	_
6-6	431-437	demand	_	_	_	_
6-7	438-440	is	_	_	_	_
6-8	441-444	not	_	_	_	_
6-9	445-454	satisfied	_	_	_	_
6-10	455-456	,	_	_	_	_
6-11	457-464	reduced	abstract[29]	new[29]	_	_
6-12	465-478	functionality	abstract[29]	new[29]	_	_
6-13	479-481	of	abstract[29]	new[29]	_	_
6-14	482-485	the	abstract[29]|object[31]	new[29]|giv[31]	_	_
6-15	486-493	thyroid	abstract[29]|object|object[31]	new[29]|giv|giv[31]	_	_
6-16	494-499	gland	abstract[29]|object[31]	new[29]|giv[31]	_	_
6-17	500-505	could	_	_	_	_
6-18	506-511	occur	_	_	_	_
6-19	512-513	(	_	_	_	_
6-20	514-528	hypothyroidism	abstract	new	_	_
6-21	529-530	)	_	_	_	_
6-22	531-535	with	_	_	_	_
6-23	536-544	negative	abstract[33]	new[33]	_	_
6-24	545-557	consequences	abstract[33]	new[33]	_	_
6-25	558-561	for	abstract[33]	new[33]	_	_
6-26	562-568	proper	abstract[33]|abstract[34]	new[33]|giv[34]	_	_
6-27	569-575	mental	abstract[33]|abstract[34]	new[33]|giv[34]	_	_
6-28	576-587	development	abstract[33]|abstract[34]	new[33]|giv[34]	_	_
6-29	588-589	,	abstract[33]	new[33]	_	_
6-30	590-594	body	abstract[33]|object|abstract[36]	new[33]|new|new[36]	_	_
6-31	595-601	growth	abstract[33]|abstract[36]	new[33]|new[36]	_	_
6-32	602-603	,	abstract[33]	new[33]	_	_
6-33	604-607	and	abstract[33]	new[33]	_	_
6-34	608-617	fertility	abstract[33]|abstract	new[33]|new	_	_
6-35	618-619	.	_	_	_	_

#Text=For these reason , diet is often integrated with I supplements , generally provided through iodized salt .
7-1	620-623	For	_	_	_	_
7-2	624-629	these	abstract[38]	new[38]	coref	10-2[81_38]
7-3	630-636	reason	abstract[38]	new[38]	_	_
7-4	637-638	,	_	_	_	_
7-5	639-643	diet	abstract	new	coref	16-29[151_0]
7-6	644-646	is	_	_	_	_
7-7	647-652	often	_	_	_	_
7-8	653-663	integrated	_	_	_	_
7-9	664-668	with	_	_	_	_
7-10	669-670	I	person|substance[41]	giv|new[41]	ana|ana	8-8|8-8
7-11	671-682	supplements	substance[41]	new[41]	_	_
7-12	683-684	,	_	_	_	_
7-13	685-694	generally	_	_	_	_
7-14	695-703	provided	_	_	_	_
7-15	704-711	through	_	_	_	_
7-16	712-719	iodized	substance[42]	new[42]	_	_
7-17	720-724	salt	substance[42]	new[42]	_	_
7-18	725-726	.	_	_	_	_

#Text=For infants , milk constitutes the only I source ; therefore , the dietary calibration of this micronutrients in dairy animals assumes relevant importance in order to obtain I-rich milk without inducing variations in animal performances .
8-1	727-730	For	_	_	_	_
8-2	731-738	infants	person	new	_	_
8-3	739-740	,	_	_	_	_
8-4	741-745	milk	substance	new	coref	8-29[53_0]
8-5	746-757	constitutes	_	_	_	_
8-6	758-761	the	abstract[46]	new[46]	_	_
8-7	762-766	only	abstract[46]	new[46]	_	_
8-8	767-768	I	person|abstract[46]	giv|new[46]	ana	9-5
8-9	769-775	source	abstract[46]	new[46]	_	_
8-10	776-777	;	_	_	_	_
8-11	778-787	therefore	_	_	_	_
8-12	788-789	,	_	_	_	_
8-13	790-793	the	abstract[48]	new[48]	_	_
8-14	794-801	dietary	abstract|abstract[48]	new|new[48]	coref	18-38
8-15	802-813	calibration	abstract[48]	new[48]	_	_
8-16	814-816	of	abstract[48]	new[48]	_	_
8-17	817-821	this	abstract[48]|abstract[49]	new[48]|new[49]	_	_
8-18	822-836	micronutrients	abstract[48]|abstract[49]	new[48]|new[49]	_	_
8-19	837-839	in	abstract[48]|abstract[49]	new[48]|new[49]	_	_
8-20	840-845	dairy	abstract[48]|abstract[49]|person|animal[51]	new[48]|new[49]|new|new[51]	coref|coref|coref|coref	11-15[0_51]|11-43|11-15[0_51]|11-43
8-21	846-853	animals	abstract[48]|abstract[49]|animal[51]	new[48]|new[49]|new[51]	_	_
8-22	854-861	assumes	_	_	_	_
8-23	862-870	relevant	abstract[52]	new[52]	_	_
8-24	871-881	importance	abstract[52]	new[52]	_	_
8-25	882-884	in	_	_	_	_
8-26	885-890	order	_	_	_	_
8-27	891-893	to	_	_	_	_
8-28	894-900	obtain	_	_	_	_
8-29	901-907	I-rich	substance[53]	giv[53]	coref	11-34[104_53]
8-30	908-912	milk	substance[53]	giv[53]	_	_
8-31	913-920	without	_	_	_	_
8-32	921-929	inducing	_	_	_	_
8-33	930-940	variations	abstract[54]	new[54]	_	_
8-34	941-943	in	abstract[54]	new[54]	_	_
8-35	944-950	animal	abstract[54]|animal|event[56]	new[54]|new|new[56]	coref|coref|coref|coref	9-2|11-11[96_56]|9-2|11-11[96_56]
8-36	951-963	performances	abstract[54]|event[56]	new[54]|new[56]	_	_
8-37	964-965	.	_	_	_	_

#Text=In animal husbandry , I supplementation as calcium iodate , sodium iodide , and other iodine compounds is needed since the native iodine content of plant straight feed-stuffs is low ; moreover , the increasing use of rapeseed meal ( RSM ) in livestock diets is associated with the intake of glucosinolates , which are known to be iodine antagonists inhibiting the activity of sodium iodide symporter .
9-1	966-968	In	_	_	_	_
9-2	969-975	animal	animal|abstract[58]	giv|new[58]	_	_
9-3	976-985	husbandry	abstract[58]	new[58]	_	_
9-4	986-987	,	_	_	_	_
9-5	988-989	I	person	giv	ana	10-18
9-6	990-1005	supplementation	_	_	_	_
9-7	1006-1008	as	_	_	_	_
9-8	1009-1016	calcium	substance	new	_	_
9-9	1017-1023	iodate	_	_	_	_
9-10	1024-1025	,	_	_	_	_
9-11	1026-1032	sodium	substance	new	coref	9-65
9-12	1033-1039	iodide	_	_	_	_
9-13	1040-1041	,	_	_	_	_
9-14	1042-1045	and	_	_	_	_
9-15	1046-1051	other	substance[63]	new[63]	_	_
9-16	1052-1058	iodine	substance|substance[63]	giv|new[63]	coref	9-23
9-17	1059-1068	compounds	substance[63]	new[63]	_	_
9-18	1069-1071	is	_	_	_	_
9-19	1072-1078	needed	_	_	_	_
9-20	1079-1084	since	_	_	_	_
9-21	1085-1088	the	abstract[65]	new[65]	coref	12-14[116_65]
9-22	1089-1095	native	abstract[65]	new[65]	_	_
9-23	1096-1102	iodine	substance|abstract[65]	giv|new[65]	coref	9-59
9-24	1103-1110	content	abstract[65]	new[65]	_	_
9-25	1111-1113	of	abstract[65]	new[65]	_	_
9-26	1114-1119	plant	abstract[65]|plant|plant[67]	new[65]|new|new[67]	_	_
9-27	1120-1128	straight	abstract[65]|plant[67]	new[65]|new[67]	_	_
9-28	1129-1140	feed-stuffs	abstract[65]|plant[67]	new[65]|new[67]	_	_
9-29	1141-1143	is	_	_	_	_
9-30	1144-1147	low	_	_	_	_
9-31	1148-1149	;	_	_	_	_
9-32	1150-1158	moreover	_	_	_	_
9-33	1159-1160	,	_	_	_	_
9-34	1161-1164	the	abstract[68]	new[68]	_	_
9-35	1165-1175	increasing	abstract[68]	new[68]	_	_
9-36	1176-1179	use	abstract[68]	new[68]	_	_
9-37	1180-1182	of	abstract[68]	new[68]	_	_
9-38	1183-1191	rapeseed	abstract[68]|substance[69]	new[68]|new[69]	appos	9-41[0_69]
9-39	1192-1196	meal	abstract[68]|substance[69]	new[68]|new[69]	_	_
9-40	1197-1198	(	_	_	_	_
9-41	1199-1202	RSM	substance	giv	_	_
9-42	1203-1204	)	_	_	_	_
9-43	1205-1207	in	_	_	_	_
9-44	1208-1217	livestock	animal|object[72]	new|new[72]	coref|coref	11-41[107_72]|11-41[107_72]
9-45	1218-1223	diets	object[72]	new[72]	_	_
9-46	1224-1226	is	_	_	_	_
9-47	1227-1237	associated	_	_	_	_
9-48	1238-1242	with	_	_	_	_
9-49	1243-1246	the	event[73]	new[73]	_	_
9-50	1247-1253	intake	event[73]	new[73]	_	_
9-51	1254-1256	of	event[73]	new[73]	_	_
9-52	1257-1271	glucosinolates	event[73]|substance	new[73]|new	_	_
9-53	1272-1273	,	_	_	_	_
9-54	1274-1279	which	_	_	_	_
9-55	1280-1283	are	_	_	_	_
9-56	1284-1289	known	_	_	_	_
9-57	1290-1292	to	_	_	_	_
9-58	1293-1295	be	_	_	_	_
9-59	1296-1302	iodine	abstract|abstract[76]	giv|new[76]	coref|coref	12-16|12-16
9-60	1303-1314	antagonists	abstract[76]	new[76]	_	_
9-61	1315-1325	inhibiting	_	_	_	_
9-62	1326-1329	the	abstract[77]	new[77]	_	_
9-63	1330-1338	activity	abstract[77]	new[77]	_	_
9-64	1339-1341	of	abstract[77]	new[77]	_	_
9-65	1342-1348	sodium	abstract[77]|substance|abstract[80]	new[77]|giv|new[80]	_	_
9-66	1349-1355	iodide	abstract[77]|place|abstract[80]	new[77]|new|new[80]	coref	15-11
9-67	1356-1365	symporter	abstract[77]|abstract[80]	new[77]|new[80]	_	_
9-68	1366-1367	.	_	_	_	_

#Text=For this reason , the European community has recently brought to 5 mg/kg the maximum level of I supplementation for milk-producing ruminants ( milk intended for human consumption ) , while it remained at 10 mg/kg of complete feed for other ruminant categories .
10-1	1368-1371	For	_	_	_	_
10-2	1372-1376	this	abstract[81]	giv[81]	_	_
10-3	1377-1383	reason	abstract[81]	giv[81]	_	_
10-4	1384-1385	,	_	_	_	_
10-5	1386-1389	the	organization[82]	new[82]	_	_
10-6	1390-1398	European	organization[82]	new[82]	_	_
10-7	1399-1408	community	organization[82]	new[82]	_	_
10-8	1409-1412	has	_	_	_	_
10-9	1413-1421	recently	_	_	_	_
10-10	1422-1429	brought	_	_	_	_
10-11	1430-1432	to	_	_	_	_
10-12	1433-1434	5	quantity[83]	new[83]	_	_
10-13	1435-1440	mg/kg	quantity[83]	new[83]	_	_
10-14	1441-1444	the	quantity[84]	new[84]	ana	10-32[0_84]
10-15	1445-1452	maximum	quantity[84]	new[84]	_	_
10-16	1453-1458	level	quantity[84]	new[84]	_	_
10-17	1459-1461	of	quantity[84]	new[84]	_	_
10-18	1462-1463	I	quantity[84]|person|substance[86]	new[84]|giv|new[86]	ana|coref|ana|coref	11-18|11-17[99_86]|11-18|11-17[99_86]
10-19	1464-1479	supplementation	quantity[84]|substance[86]	new[84]|new[86]	_	_
10-20	1480-1483	for	quantity[84]|substance[86]	new[84]|new[86]	_	_
10-21	1484-1498	milk-producing	quantity[84]|substance[86]|substance[87]	new[84]|new[86]|new[87]	appos	10-24[0_87]
10-22	1499-1508	ruminants	quantity[84]|substance[86]|substance[87]	new[84]|new[86]|new[87]	_	_
10-23	1509-1510	(	_	_	_	_
10-24	1511-1515	milk	substance	giv	coref	12-7[111_0]
10-25	1516-1524	intended	_	_	_	_
10-26	1525-1528	for	_	_	_	_
10-27	1529-1534	human	abstract[89]	new[89]	_	_
10-28	1535-1546	consumption	abstract[89]	new[89]	_	_
10-29	1547-1548	)	_	_	_	_
10-30	1549-1550	,	_	_	_	_
10-31	1551-1556	while	_	_	_	_
10-32	1557-1559	it	quantity	giv	_	_
10-33	1560-1568	remained	_	_	_	_
10-34	1569-1571	at	_	_	_	_
10-35	1572-1574	10	abstract[91]	new[91]	_	_
10-36	1575-1580	mg/kg	abstract[91]	new[91]	_	_
10-37	1581-1583	of	abstract[91]	new[91]	_	_
10-38	1584-1592	complete	abstract[91]|abstract[92]	new[91]|new[92]	_	_
10-39	1593-1597	feed	abstract[91]|abstract[92]	new[91]|new[92]	_	_
10-40	1598-1601	for	abstract[91]|abstract[92]	new[91]|new[92]	_	_
10-41	1602-1607	other	abstract[91]|abstract[92]|abstract[94]	new[91]|new[92]|new[94]	_	_
10-42	1608-1616	ruminant	abstract[91]|abstract[92]|abstract|abstract[94]	new[91]|new[92]|new|new[94]	_	_
10-43	1617-1627	categories	abstract[91]|abstract[92]|abstract[94]	new[91]|new[92]|new[94]	_	_
10-44	1628-1629	.	_	_	_	_

#Text=Consequently , several studies have been carried out to evaluate the productive performances in animals fed the I supplementation . Weiss et al. showed that I concentration increased in serum but not in milk after supplementation of this element in diets of dairy cows .
11-1	1630-1642	Consequently	_	_	_	_
11-2	1643-1644	,	_	_	_	_
11-3	1645-1652	several	event[95]	new[95]	coref	12-4[0_95]
11-4	1653-1660	studies	event[95]	new[95]	_	_
11-5	1661-1665	have	_	_	_	_
11-6	1666-1670	been	_	_	_	_
11-7	1671-1678	carried	_	_	_	_
11-8	1679-1682	out	_	_	_	_
11-9	1683-1685	to	_	_	_	_
11-10	1686-1694	evaluate	_	_	_	_
11-11	1695-1698	the	event[96]	giv[96]	_	_
11-12	1699-1709	productive	event[96]	giv[96]	_	_
11-13	1710-1722	performances	event[96]	giv[96]	_	_
11-14	1723-1725	in	event[96]	giv[96]	_	_
11-15	1726-1733	animals	event[96]|animal	giv[96]|giv	_	_
11-16	1734-1737	fed	_	_	_	_
11-17	1738-1741	the	substance[99]	giv[99]	coref	11-36[105_99]
11-18	1742-1743	I	person|substance[99]	giv|giv[99]	ana	11-26
11-19	1744-1759	supplementation	substance[99]	giv[99]	_	_
11-20	1760-1761	.	_	_	_	_
11-21	1762-1767	Weiss	person	new	_	_
11-22	1768-1770	et	_	_	_	_
11-23	1771-1774	al.	_	_	_	_
11-24	1775-1781	showed	_	_	_	_
11-25	1782-1786	that	_	_	_	_
11-26	1787-1788	I	person	giv	ana	12-11
11-27	1789-1802	concentration	abstract	new	_	_
11-28	1803-1812	increased	_	_	_	_
11-29	1813-1815	in	_	_	_	_
11-30	1816-1821	serum	substance	new	_	_
11-31	1822-1825	but	_	_	_	_
11-32	1826-1829	not	_	_	_	_
11-33	1830-1832	in	_	_	_	_
11-34	1833-1837	milk	substance[104]	giv[104]	coref	12-15[0_104]
11-35	1838-1843	after	substance[104]	giv[104]	_	_
11-36	1844-1859	supplementation	substance[104]|substance[105]	giv[104]|giv[105]	coref	12-12[0_105]
11-37	1860-1862	of	substance[104]|substance[105]	giv[104]|giv[105]	_	_
11-38	1863-1867	this	substance[104]|substance[105]|substance[106]	giv[104]|giv[105]|new[106]	_	_
11-39	1868-1875	element	substance[104]|substance[105]|substance[106]	giv[104]|giv[105]|new[106]	_	_
11-40	1876-1878	in	substance[104]|substance[105]	giv[104]|giv[105]	_	_
11-41	1879-1884	diets	substance[104]|substance[105]|object[107]	giv[104]|giv[105]|giv[107]	_	_
11-42	1885-1887	of	substance[104]|substance[105]|object[107]	giv[104]|giv[105]|giv[107]	_	_
11-43	1888-1893	dairy	substance[104]|substance[105]|object[107]|person|animal[109]	giv[104]|giv[105]|giv[107]|giv|new[109]	coref|coref|coref|coref	17-19|17-19[161_109]|17-19|17-19[161_109]
11-44	1894-1898	cows	substance[104]|substance[105]|object[107]|animal[109]	giv[104]|giv[105]|giv[107]|new[109]	_	_
11-45	1899-1900	.	_	_	_	_

#Text=In contrast , studies performed in small ruminants showed that I supplementation doubled the milk iodine content when compared with the control group , even though no evident effect was observed in the milk gross composition .
12-1	1901-1903	In	_	_	_	_
12-2	1904-1912	contrast	_	_	_	_
12-3	1913-1914	,	_	_	_	_
12-4	1915-1922	studies	event	giv	coref	18-30[172_0]
12-5	1923-1932	performed	_	_	_	_
12-6	1933-1935	in	_	_	_	_
12-7	1936-1941	small	substance[111]	giv[111]	coref	18-23[169_111]
12-8	1942-1951	ruminants	substance[111]	giv[111]	_	_
12-9	1952-1958	showed	_	_	_	_
12-10	1959-1963	that	_	_	_	_
12-11	1964-1965	I	person	giv	ana	13-1
12-12	1966-1981	supplementation	substance	giv	coref	13-2
12-13	1982-1989	doubled	_	_	_	_
12-14	1990-1993	the	abstract[116]	giv[116]	_	_
12-15	1994-1998	milk	substance|abstract[116]	giv|giv[116]	coref	12-33[119_0]
12-16	1999-2005	iodine	substance|abstract[116]	giv|giv[116]	coref	18-39
12-17	2006-2013	content	abstract[116]	giv[116]	_	_
12-18	2014-2018	when	_	_	_	_
12-19	2019-2027	compared	_	_	_	_
12-20	2028-2032	with	_	_	_	_
12-21	2033-2036	the	abstract[117]	new[117]	_	_
12-22	2037-2044	control	abstract[117]	new[117]	_	_
12-23	2045-2050	group	abstract[117]	new[117]	_	_
12-24	2051-2052	,	_	_	_	_
12-25	2053-2057	even	_	_	_	_
12-26	2058-2064	though	_	_	_	_
12-27	2065-2067	no	abstract[118]	new[118]	_	_
12-28	2068-2075	evident	abstract[118]	new[118]	_	_
12-29	2076-2082	effect	abstract[118]	new[118]	_	_
12-30	2083-2086	was	_	_	_	_
12-31	2087-2095	observed	_	_	_	_
12-32	2096-2098	in	_	_	_	_
12-33	2099-2102	the	substance[119]	giv[119]	coref	18-23[0_119]
12-34	2103-2107	milk	substance[119]	giv[119]	_	_
12-35	2108-2113	gross	substance[119]	giv[119]	_	_
12-36	2114-2125	composition	substance[119]|abstract	giv[119]|new	_	_
12-37	2126-2127	.	_	_	_	_

#Text=I supplementation showed also beneficial effects on healthy status .
13-1	2128-2129	I	person	giv	ana	16-19
13-2	2130-2145	supplementation	substance	giv	coref	15-9[136_0]
13-3	2146-2152	showed	_	_	_	_
13-4	2153-2157	also	_	_	_	_
13-5	2158-2168	beneficial	abstract[123]	new[123]	coref	16-25[150_123]
13-6	2169-2176	effects	abstract[123]	new[123]	_	_
13-7	2177-2179	on	abstract[123]	new[123]	_	_
13-8	2180-2187	healthy	abstract[123]|abstract[124]	new[123]|new[124]	_	_
13-9	2188-2194	status	abstract[123]|abstract[124]	new[123]|new[124]	_	_
13-10	2195-2196	.	_	_	_	_

#Text=Indeed , early study on feedlot cattle demonstrated an increased resistance to foot rot , which is due to improved phagocytic cell function .
14-1	2197-2203	Indeed	_	_	_	_
14-2	2204-2205	,	_	_	_	_
14-3	2206-2211	early	abstract[125]	new[125]	_	_
14-4	2212-2217	study	abstract[125]	new[125]	_	_
14-5	2218-2220	on	abstract[125]	new[125]	_	_
14-6	2221-2228	feedlot	abstract[125]|animal|animal[127]	new[125]|new|new[127]	_	_
14-7	2229-2235	cattle	abstract[125]|animal[127]	new[125]|new[127]	_	_
14-8	2236-2248	demonstrated	_	_	_	_
14-9	2249-2251	an	abstract[128]	new[128]	_	_
14-10	2252-2261	increased	abstract[128]	new[128]	_	_
14-11	2262-2272	resistance	abstract[128]	new[128]	_	_
14-12	2273-2275	to	abstract[128]	new[128]	_	_
14-13	2276-2280	foot	abstract[128]	new[128]	_	_
14-14	2281-2284	rot	abstract[128]|event	new[128]|new	ana	15-3
14-15	2285-2286	,	_	_	_	_
14-16	2287-2292	which	_	_	_	_
14-17	2293-2295	is	_	_	_	_
14-18	2296-2299	due	_	_	_	_
14-19	2300-2302	to	_	_	_	_
14-20	2303-2311	improved	abstract[131]	new[131]	_	_
14-21	2312-2322	phagocytic	abstract[131]	new[131]	_	_
14-22	2323-2327	cell	object|abstract[131]	new|new[131]	_	_
14-23	2328-2336	function	abstract[131]	new[131]	_	_
14-24	2337-2338	.	_	_	_	_

#Text=Moreover , it was shown in lambs that high-dose potassium iodide supplementation can be effective to decrease the severity of airway viral infections , supposedly through the augmentation of mucosal oxidative defenses .
15-1	2339-2347	Moreover	_	_	_	_
15-2	2348-2349	,	_	_	_	_
15-3	2350-2352	it	event	giv	_	_
15-4	2353-2356	was	_	_	_	_
15-5	2357-2362	shown	_	_	_	_
15-6	2363-2365	in	_	_	_	_
15-7	2366-2371	lambs	animal	new	_	_
15-8	2372-2376	that	_	_	_	_
15-9	2377-2386	high-dose	substance[136]	giv[136]	coref	16-19[148_136]
15-10	2387-2396	potassium	substance|substance[136]	new|giv[136]	_	_
15-11	2397-2403	iodide	place|substance[136]	giv|giv[136]	_	_
15-12	2404-2419	supplementation	substance[136]	giv[136]	_	_
15-13	2420-2423	can	_	_	_	_
15-14	2424-2426	be	_	_	_	_
15-15	2427-2436	effective	_	_	_	_
15-16	2437-2439	to	_	_	_	_
15-17	2440-2448	decrease	_	_	_	_
15-18	2449-2452	the	abstract[137]	new[137]	_	_
15-19	2453-2461	severity	abstract[137]	new[137]	_	_
15-20	2462-2464	of	abstract[137]	new[137]	_	_
15-21	2465-2471	airway	abstract[137]|place|abstract[140]	new[137]|new|new[140]	_	_
15-22	2472-2477	viral	abstract[137]|object|abstract[140]	new[137]|new|new[140]	_	_
15-23	2478-2488	infections	abstract[137]|abstract[140]	new[137]|new[140]	_	_
15-24	2489-2490	,	_	_	_	_
15-25	2491-2501	supposedly	abstract[141]	new[141]	_	_
15-26	2502-2509	through	abstract[141]	new[141]	_	_
15-27	2510-2513	the	abstract[141]	new[141]	_	_
15-28	2514-2526	augmentation	abstract[141]	new[141]	_	_
15-29	2527-2529	of	abstract[141]	new[141]	_	_
15-30	2530-2537	mucosal	abstract[141]|abstract[143]	new[141]|new[143]	_	_
15-31	2538-2547	oxidative	abstract[141]|abstract|abstract[143]	new[141]|new|new[143]	_	_
15-32	2548-2556	defenses	abstract[141]|abstract[143]	new[141]|new[143]	_	_
15-33	2557-2558	.	_	_	_	_

#Text=Recently , the RNA-sequencing approach was shown to be useful to elucidate which molecular pathways are affected by I supplementation in sheeps and showed the positive effects of olive pomace-supplemented diet on inflammation and cholesterol in laying hens .
16-1	2559-2567	Recently	_	_	_	_
16-2	2568-2569	,	_	_	_	_
16-3	2570-2573	the	abstract[145]	new[145]	_	_
16-4	2574-2588	RNA-sequencing	abstract|abstract[145]	new|new[145]	_	_
16-5	2589-2597	approach	abstract[145]	new[145]	_	_
16-6	2598-2601	was	_	_	_	_
16-7	2602-2607	shown	_	_	_	_
16-8	2608-2610	to	_	_	_	_
16-9	2611-2613	be	_	_	_	_
16-10	2614-2620	useful	_	_	_	_
16-11	2621-2623	to	_	_	_	_
16-12	2624-2633	elucidate	_	_	_	_
16-13	2634-2639	which	abstract[146]	new[146]	coref	18-10[164_146]
16-14	2640-2649	molecular	abstract[146]	new[146]	_	_
16-15	2650-2658	pathways	abstract[146]	new[146]	_	_
16-16	2659-2662	are	_	_	_	_
16-17	2663-2671	affected	_	_	_	_
16-18	2672-2674	by	_	_	_	_
16-19	2675-2676	I	person|substance[148]	giv|giv[148]	ana|coref|ana|coref	17-13|17-13[158_148]|17-13|17-13[158_148]
16-20	2677-2692	supplementation	substance[148]	giv[148]	_	_
16-21	2693-2695	in	substance[148]	giv[148]	_	_
16-22	2696-2702	sheeps	substance[148]|animal	giv[148]|new	_	_
16-23	2703-2706	and	_	_	_	_
16-24	2707-2713	showed	_	_	_	_
16-25	2714-2717	the	abstract[150]	giv[150]	_	_
16-26	2718-2726	positive	abstract[150]	giv[150]	_	_
16-27	2727-2734	effects	abstract[150]	giv[150]	_	_
16-28	2735-2737	of	abstract[150]	giv[150]	_	_
16-29	2738-2743	olive	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
16-30	2744-2763	pomace-supplemented	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
16-31	2764-2768	diet	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
16-32	2769-2771	on	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
16-33	2772-2784	inflammation	abstract[150]|abstract[151]|abstract	giv[150]|giv[151]|new	_	_
16-34	2785-2788	and	abstract[150]|abstract[151]	giv[150]|giv[151]	_	_
16-35	2789-2800	cholesterol	abstract[150]|abstract[151]|substance	giv[150]|giv[151]|new	_	_
16-36	2801-2803	in	_	_	_	_
16-37	2804-2810	laying	_	_	_	_
16-38	2811-2815	hens	animal	new	_	_
16-39	2816-2817	.	_	_	_	_

#Text=However , to date , little is known about the effects of I supplementation on transcriptomic profiles in dairy cows .
17-1	2818-2825	However	_	_	_	_
17-2	2826-2827	,	_	_	_	_
17-3	2828-2830	to	_	_	_	_
17-4	2831-2835	date	time	new	_	_
17-5	2836-2837	,	_	_	_	_
17-6	2838-2844	little	_	_	_	_
17-7	2845-2847	is	_	_	_	_
17-8	2848-2853	known	_	_	_	_
17-9	2854-2859	about	_	_	_	_
17-10	2860-2863	the	abstract[156]	new[156]	_	_
17-11	2864-2871	effects	abstract[156]	new[156]	_	_
17-12	2872-2874	of	abstract[156]	new[156]	_	_
17-13	2875-2876	I	abstract[156]|person|substance[158]	new[156]|giv|giv[158]	ana|coref|ana|coref	18-15|18-15[166_158]|18-15|18-15[166_158]
17-14	2877-2892	supplementation	abstract[156]|substance[158]	new[156]|giv[158]	_	_
17-15	2893-2895	on	abstract[156]|substance[158]	new[156]|giv[158]	_	_
17-16	2896-2910	transcriptomic	abstract[156]|substance[158]|object[159]	new[156]|giv[158]|new[159]	_	_
17-17	2911-2919	profiles	abstract[156]|substance[158]|object[159]	new[156]|giv[158]|new[159]	_	_
17-18	2920-2922	in	abstract[156]|substance[158]|object[159]	new[156]|giv[158]|new[159]	_	_
17-19	2923-2928	dairy	abstract[156]|substance[158]|object[159]|animal|animal[161]	new[156]|giv[158]|new[159]|giv|giv[161]	_	_
17-20	2929-2933	cows	abstract[156]|substance[158]|object[159]|animal[161]	new[156]|giv[158]|new[159]|giv[161]	_	_
17-21	2934-2935	.	_	_	_	_

#Text=Moreover , we tried to correlate the information concerning the signaling pathways influenced by I supplementation , with the qualitative parameters of milk and derivatives , taking into account those studies in which it was shown that dietary iodine supplementation in ruminants contributes to an improvement in the quality of dairy products .
18-1	2936-2944	Moreover	_	_	_	_
18-2	2945-2946	,	_	_	_	_
18-3	2947-2949	we	person	acc	_	_
18-4	2950-2955	tried	_	_	_	_
18-5	2956-2958	to	_	_	_	_
18-6	2959-2968	correlate	_	_	_	_
18-7	2969-2972	the	abstract[163]	new[163]	_	_
18-8	2973-2984	information	abstract[163]	new[163]	_	_
18-9	2985-2995	concerning	_	_	_	_
18-10	2996-2999	the	abstract[164]	giv[164]	_	_
18-11	3000-3009	signaling	abstract[164]	giv[164]	_	_
18-12	3010-3018	pathways	abstract[164]	giv[164]	_	_
18-13	3019-3029	influenced	_	_	_	_
18-14	3030-3032	by	_	_	_	_
18-15	3033-3034	I	person|substance[166]	giv|giv[166]	coref|coref	18-38[176_166]|18-38[176_166]
18-16	3035-3050	supplementation	substance[166]	giv[166]	_	_
18-17	3051-3052	,	_	_	_	_
18-18	3053-3057	with	_	_	_	_
18-19	3058-3061	the	abstract[167]	new[167]	_	_
18-20	3062-3073	qualitative	abstract[167]	new[167]	_	_
18-21	3074-3084	parameters	abstract[167]	new[167]	_	_
18-22	3085-3087	of	abstract[167]	new[167]	_	_
18-23	3088-3092	milk	abstract[167]|substance|substance[169]	new[167]|giv|giv[169]	coref|coref	18-42[0_169]|18-42[0_169]
18-24	3093-3096	and	abstract[167]|substance[169]	new[167]|giv[169]	_	_
18-25	3097-3108	derivatives	abstract[167]|substance[169]|substance	new[167]|giv[169]|new	_	_
18-26	3109-3110	,	_	_	_	_
18-27	3111-3117	taking	_	_	_	_
18-28	3118-3122	into	_	_	_	_
18-29	3123-3130	account	abstract	new	ana	18-34
18-30	3131-3136	those	event[172]	giv[172]	_	_
18-31	3137-3144	studies	event[172]	giv[172]	_	_
18-32	3145-3147	in	_	_	_	_
18-33	3148-3153	which	_	_	_	_
18-34	3154-3156	it	abstract	giv	_	_
18-35	3157-3160	was	_	_	_	_
18-36	3161-3166	shown	_	_	_	_
18-37	3167-3171	that	_	_	_	_
18-38	3172-3179	dietary	abstract|substance[176]	giv|giv[176]	_	_
18-39	3180-3186	iodine	substance|substance[176]	giv|giv[176]	_	_
18-40	3187-3202	supplementation	substance[176]	giv[176]	_	_
18-41	3203-3205	in	substance[176]	giv[176]	_	_
18-42	3206-3215	ruminants	substance[176]|substance	giv[176]|giv	_	_
18-43	3216-3227	contributes	_	_	_	_
18-44	3228-3230	to	_	_	_	_
18-45	3231-3233	an	abstract[178]	new[178]	_	_
18-46	3234-3245	improvement	abstract[178]	new[178]	_	_
18-47	3246-3248	in	abstract[178]	new[178]	_	_
18-48	3249-3252	the	abstract[178]|abstract[179]	new[178]|new[179]	_	_
18-49	3253-3260	quality	abstract[178]|abstract[179]	new[178]|new[179]	_	_
18-50	3261-3263	of	abstract[178]|abstract[179]	new[178]|new[179]	_	_
18-51	3264-3269	dairy	abstract[178]|abstract[179]|substance[180]	new[178]|new[179]|new[180]	_	_
18-52	3270-3278	products	abstract[178]|abstract[179]|substance[180]	new[178]|new[179]|new[180]	_	_
18-53	3279-3280	.	_	_	_	_
